PD-L1 expression was detected in 21 (30.4%) and 11 (15.9%) of 69 post-EGFR-TKI specimens using cut-offs of 1–49% and ≥50% in tumor proportion score (TPS; see Methods), respectively (Table 2). The gene discussed is CD274; the disease is neoplasm.